Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (105)	9/18/1998 2:01:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 1073

Hmmm NRGN bouncing around a little bit more than usual today, also noticed my NTII actually has some volume for a change today. Richard, what do you know about NGD 96-1?? I'm a bit of an insomniac myself, but have just learned to suffer through--comes with working a rotating shift I guess. We have a few people at work poppin' melatonin, but I don't get anything from the stuff, and usually use the time I'm up at nite to catch up on my reading. Speaking of which, have you had a chance to read the BTRN article in Science? Do you have cash you can put to work sitting in the T/FIF portfolio, or are you paper trading? I wonder if we wont have some more rough days for the markets in general. Heard a blurb that said S&P 3Q earnings estimate is now minus 0.2%--negative earnings growth --geeze, how did that sneak up on me. If we see more days with the Dow down triple digits, there will plenty more cherry picking opportunities for the biotechs, especially the micros (there must be a lot of weak hands trading on margin--I don't understand why anybody would sell their thinly traded micro biotech on a down day in the markets--and yet it happens). Well, anyway, I took gains in a couple things today (not biotech, because of course I have no gains to take there, ha ha) and will continue to watch the quotes closely over the next couple months, geeze, if the markets continue to trend down, by the time we hit tax loss selling season, the landscape with be littered with bargains even more so than now. Do you suppose we are missing something though? Drug discovery stocks which trade, in many cases, at less than book value... You would think that the major pharmaceutical companies would be out there cherry picking these things too by now. Wont have a chance to chat it up on the threads over the weekend, but see ya next week. By then my Fidelity Select semiannual report should have arrived in the mail--it's always fun to see what FBIOX has been juggling. --MM

To: scaram(o)uche who wrote (105)	9/18/1998 2:56:00 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 1073

Arrrrggggghhhh........ I can't make the SI portfolio tracker work for real-world stuff. I'd like the "totals" row at the bottom to reflect performance to date (including purchases and sales), not performance of the portfolio as shown. Doesn't work that way. techstocks.com So..... the second of the two "$" rows reflects the "Bounce" loss in AVIR. I added this row to keep the tax cost constant at our beginning $100K. Unfortunately, I can't override the "current value" cell for this row to make it zero, which means that the "current value" and "portfolio change" totals look better than they actually are. The true "current value" total for the portfolio can be calculated by subtracting the "current value" shown for the second "$" row. The portfolio tracking program needs to provide the user with a "fudge" row, where one can keep track of past gains/losses such that the tax basis can be maintained at a starting value (e.g., our $100K) and such that the totals row reflects performance to date.